July 15 (SeeNews) - Slovenian pharmaceuticals distributor Salus said it has signed an agreement with the UK-based Europe, Middle Est and Africa (EMEA) hub of Tokyo-based pharmaceutical company Eisai for the distribution of lecanemab medication used for the treatment of Alzheimer's disease, across Slovenia, Croatia, Poland, Hungary and the Baltic states.